Inloggad som:

PSMA Fore

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.

PSMA Fore
Phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of Novel Androgen Axis Drugs in the Treatment of Taxane Naïve Men with Progressive Metastatic Castrate Resistant Prostate Cancer
Phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of Novel Androgen Axis Drugs in the Treatment of Taxane Naïve Men with Progressive Metastatic Castrate Resistant Prostate Cancer
PLACEHOLDER
Lutetium-behandling vid 6 tillfällen till patienter med PSMA-positiv PET/CT.
Mer information om studien för vårdgivare
Behandling
Fas 3
Palliativ
Företag

Studien ändrades senast av: studyjohanna (2021-09-11)

Tillbaka till listan